SEC EDGAR · Company announcement
TDG: Other company developments
Filed 8-K for an event or period dated 2026-09-28. Other company developments.
Follow TDG- Became public
- Sep 28, 2026, 7:42 AM EDT
- Event / period date
- Sep 28, 2026
- Collected
- Nov 8, 2026, 6:57 AM EST
Why this is connected
This filing identifies TransDigm Group INC as the issuer of the security. The company's SEC identifier connects it to TDG.
Press Release ↗Source evidence
Read the source excerpt or record
Item 8.01. Other Events. On September 28, 2026, TransDigm Group Incorporated (“TransDigm Group”) issued a press release (the “Press Release”) announcing the completion of the acquisition of Prince & Izant (“P&I” or “the Company”), formerly a portfolio company of Industrial Growth Partners, for approximately $1.066 billion in cash, including certain tax benefits. TransDigm Group financed the acquisition of the Company through cash on hand. The entry into the definitive agreement to acquire P&I was previously reported in a Current Report on Form 8-K filed on July 27, 2026. A copy of this Press Release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference. Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TRANSDIGM GROUP INCORPORATED By: /s/ Armani Vadiee Name: Armani Vadiee Title: General Counsel, Chief Compliance Officer and Secretary Dated: September 28, 2026
Congressional trading in TDG
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Sep 9, 2026$100K–$250K
Rep. April McClain Delaney (D-MD-6)
$100K–$250K · Traded Aug 25, 2026 · disclosed Sep 9, 2026 · Dependent
Committee overlap: Science - Aug 3, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded Jul 28, 2026 · disclosed Aug 3, 2026 · Dependent
Committee overlap: ScienceTraded 7 days before earnings - Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
- Jun 5, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded May 22, 2026 · disclosed Jun 5, 2026 · Dependent
Committee overlap: Science - Jun 5, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded May 21, 2026 · disclosed Jun 5, 2026 · Dependent
Committee overlap: Science - Jun 5, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded May 13, 2026 · disclosed Jun 5, 2026 · Dependent
Committee overlap: Science - Jun 5, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded May 8, 2026 · disclosed Jun 5, 2026 · Dependent
Committee overlap: Science - Jun 5, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded May 7, 2026 · disclosed Jun 5, 2026 · Dependent
Committee overlap: Science
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.